
Completing the DTaP primary series was 96.2% effective against pertussis in Alaska children aged 6 months to 6 years during a record 2024 outbreak.
The Food and Drug Administration (FDA) recently approved several agents for use in pediatric patients, including a new cervical cancer vaccine and a seasonal influenza vaccine.
The Food and Drug Administration (FDA) recently approved several agents for use in pediatric patients, including a new cervical cancer vaccine and a seasonal influenza vaccine. The agency also approved a new indication for the vaccine Gardasil; the agent can now be used for the prevention of genital warts caused by human papillomavirus (HPV) in boys and men aged 9 to 26 years.






